Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9007 |
High Similarity |
NPD4628 |
Phase 3 |
0.8803 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8667 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8618 |
High Similarity |
NPD7075 |
Discontinued |
0.8477 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8467 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8312 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8311 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8301 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8289 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8258 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.825 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8182 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8138 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8117 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8105 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8099 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8099 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8082 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8074 |
Intermediate Similarity |
NPD9545 |
Approved |
0.8056 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.8027 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8027 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7973 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7972 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7959 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7949 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7931 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7931 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7922 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7908 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7905 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7905 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7905 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7905 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7867 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7848 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7843 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.784 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.784 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7815 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7806 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7793 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7792 |
Intermediate Similarity |
NPD920 |
Approved |
0.7786 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7786 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7785 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7785 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7778 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7778 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD5401 |
Approved |
0.777 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.777 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7748 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD1240 |
Approved |
0.774 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7736 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7733 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7718 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7712 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7703 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7702 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7687 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7687 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7682 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7682 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7671 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7662 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7651 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7647 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7632 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7622 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7622 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7619 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD6273 |
Approved |
0.761 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7607 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7605 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7603 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7603 |
Intermediate Similarity |
NPD3268 |
Approved |
0.76 |
Intermediate Similarity |
NPD4476 |
Approved |
0.76 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7597 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7595 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7589 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7578 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7574 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7574 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7574 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7572 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7571 |
Intermediate Similarity |
NPD17 |
Approved |
0.7566 |
Intermediate Similarity |
NPD2800 |
Approved |
0.756 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7552 |
Intermediate Similarity |
NPD8651 |
Approved |
0.755 |
Intermediate Similarity |
NPD2353 |
Approved |
0.755 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7546 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7544 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD919 |
Approved |
0.7518 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD1512 |
Approved |
0.75 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.747 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7463 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.745 |
Intermediate Similarity |
NPD1933 |
Approved |
0.745 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7448 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7447 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7439 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7434 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7431 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7429 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7413 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7413 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD1653 |
Approved |
0.74 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7388 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7386 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7384 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7383 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7383 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7383 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7375 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7375 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7372 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7365 |
Intermediate Similarity |
NPD411 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7342 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD3863 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7338 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7325 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7322 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7321 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7305 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7289 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7286
|
Intermediate Similarity |
NPD9493 |
Approved |